460 related articles for article (PubMed ID: 23086238)
1. Elf5 inhibits the epithelial-mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2.
Chakrabarti R; Hwang J; Andres Blanco M; Wei Y; Lukačišin M; Romano RA; Smalley K; Liu S; Yang Q; Ibrahim T; Mercatali L; Amadori D; Haffty BG; Sinha S; Kang Y
Nat Cell Biol; 2012 Nov; 14(11):1212-22. PubMed ID: 23086238
[TBL] [Abstract][Full Text] [Related]
2. Setting Snail2's pace during EMT.
Mathsyaraja H; Ostrowski MC
Nat Cell Biol; 2012 Nov; 14(11):1122-3. PubMed ID: 23131919
[TBL] [Abstract][Full Text] [Related]
3. Tead2 expression levels control the subcellular distribution of Yap and Taz, zyxin expression and epithelial-mesenchymal transition.
Diepenbruck M; Waldmeier L; Ivanek R; Berninger P; Arnold P; van Nimwegen E; Christofori G
J Cell Sci; 2014 Apr; 127(Pt 7):1523-36. PubMed ID: 24554433
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide search identifies Ccnd2 as a direct transcriptional target of Elf5 in mouse mammary gland.
Escamilla-Hernandez R; Chakrabarti R; Romano RA; Smalley K; Zhu Q; Lai W; Halfon MS; Buck MJ; Sinha S
BMC Mol Biol; 2010 Sep; 11():68. PubMed ID: 20831799
[TBL] [Abstract][Full Text] [Related]
5. EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice.
Morel AP; Hinkal GW; Thomas C; Fauvet F; Courtois-Cox S; Wierinckx A; Devouassoux-Shisheboran M; Treilleux I; Tissier A; Gras B; Pourchet J; Puisieux I; Browne GJ; Spicer DB; Lachuer J; Ansieau S; Puisieux A
PLoS Genet; 2012; 8(5):e1002723. PubMed ID: 22654675
[TBL] [Abstract][Full Text] [Related]
6. Elf5 inhibits TGF-β-driven epithelial-mesenchymal transition in prostate cancer by repressing SMAD3 activation.
Yao B; Zhao J; Li Y; Li H; Hu Z; Pan P; Zhang Y; Du E; Liu R; Xu Y
Prostate; 2015 Jun; 75(8):872-82. PubMed ID: 25728398
[TBL] [Abstract][Full Text] [Related]
7. Elf5 conditional knockout mice reveal its role as a master regulator in mammary alveolar development: failure of Stat5 activation and functional differentiation in the absence of Elf5.
Choi YS; Chakrabarti R; Escamilla-Hernandez R; Sinha S
Dev Biol; 2009 May; 329(2):227-41. PubMed ID: 19269284
[TBL] [Abstract][Full Text] [Related]
8. Elf5 regulates mammary gland stem/progenitor cell fate by influencing notch signaling.
Chakrabarti R; Wei Y; Romano RA; DeCoste C; Kang Y; Sinha S
Stem Cells; 2012 Jul; 30(7):1496-508. PubMed ID: 22523003
[TBL] [Abstract][Full Text] [Related]
9. ELF5 suppresses estrogen sensitivity and underpins the acquisition of antiestrogen resistance in luminal breast cancer.
Kalyuga M; Gallego-Ortega D; Lee HJ; Roden DL; Cowley MJ; Caldon CE; Stone A; Allerdice SL; Valdes-Mora F; Launchbury R; Statham AL; Armstrong N; Alles MC; Young A; Egger A; Au W; Piggin CL; Evans CJ; Ledger A; Brummer T; Oakes SR; Kaplan W; Gee JM; Nicholson RI; Sutherland RL; Swarbrick A; Naylor MJ; Clark SJ; Carroll JS; Ormandy CJ
PLoS Biol; 2012; 10(12):e1001461. PubMed ID: 23300383
[TBL] [Abstract][Full Text] [Related]
10. The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.
Taylor MA; Parvani JG; Schiemann WP
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):169-90. PubMed ID: 20467795
[TBL] [Abstract][Full Text] [Related]
11. ELF5 Drives Lung Metastasis in Luminal Breast Cancer through Recruitment of Gr1+ CD11b+ Myeloid-Derived Suppressor Cells.
Gallego-Ortega D; Ledger A; Roden DL; Law AM; Magenau A; Kikhtyak Z; Cho C; Allerdice SL; Lee HJ; Valdes-Mora F; Herrmann D; Salomon R; Young AI; Lee BY; Sergio CM; Kaplan W; Piggin C; Conway JR; Rabinovich B; Millar EK; Oakes SR; Chtanova T; Swarbrick A; Naylor MJ; O'Toole S; Green AR; Timpson P; Gee JM; Ellis IO; Clark SJ; Ormandy CJ
PLoS Biol; 2015 Dec; 13(12):e1002330. PubMed ID: 26717410
[TBL] [Abstract][Full Text] [Related]
12. Oncofetal H19 RNA promotes tumor metastasis.
Matouk IJ; Raveh E; Abu-lail R; Mezan S; Gilon M; Gershtain E; Birman T; Gallula J; Schneider T; Barkali M; Richler C; Fellig Y; Sorin V; Hubert A; Hochberg A; Czerniak A
Biochim Biophys Acta; 2014 Jul; 1843(7):1414-26. PubMed ID: 24703882
[TBL] [Abstract][Full Text] [Related]
13. WWOX regulates the Elf5/Snail1 pathway to affect epithelial-mesenchymal transition of ovarian carcinoma cells in vitro.
Xu Y; Yan YC; Hu YK; Fang LS; Li Q; Xu J; Yan HC
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1041-1053. PubMed ID: 32096174
[TBL] [Abstract][Full Text] [Related]
14. A major site of expression of the ets transcription factor Elf5 is epithelia of exocrine glands.
Lapinskas EJ; Palmer J; Ricardo S; Hertzog PJ; Hammacher A; Pritchard MA
Histochem Cell Biol; 2004 Dec; 122(6):521-6. PubMed ID: 15655699
[TBL] [Abstract][Full Text] [Related]
15. Smad3-mediated recruitment of the methyltransferase SETDB1/ESET controls
Du D; Katsuno Y; Meyer D; Budi EH; Chen SH; Koeppen H; Wang H; Akhurst RJ; Derynck R
EMBO Rep; 2018 Jan; 19(1):135-155. PubMed ID: 29233829
[TBL] [Abstract][Full Text] [Related]
16. Core needle biopsy of breast cancer tumors increases distant metastases in a mouse model.
Mathenge EG; Dean CA; Clements D; Vaghar-Kashani A; Photopoulos S; Coyle KM; Giacomantonio M; Malueth B; Nunokawa A; Jordan J; Lewis JD; Gujar SA; Marcato P; Lee PW; Giacomantonio CA
Neoplasia; 2014 Nov; 16(11):950-60. PubMed ID: 25425969
[TBL] [Abstract][Full Text] [Related]
17. Transcript profiling of Elf5+/- mammary glands during pregnancy identifies novel targets of Elf5.
Rogers RL; Van Seuningen I; Gould J; Hertzog PJ; Naylor MJ; Pritchard MA
PLoS One; 2010 Oct; 5(10):e13150. PubMed ID: 20949099
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic regulation of Elf5 is associated with epithelial-mesenchymal transition in urothelial cancer.
Wu B; Cao X; Liang X; Zhang X; Zhang W; Sun G; Wang D
PLoS One; 2015; 10(1):e0117510. PubMed ID: 25629735
[TBL] [Abstract][Full Text] [Related]
19. Lineage specific methylation of the Elf5 promoter in mammary epithelial cells.
Lee HJ; Hinshelwood RA; Bouras T; Gallego-Ortega D; Valdés-Mora F; Blazek K; Visvader JE; Clark SJ; Ormandy CJ
Stem Cells; 2011 Oct; 29(10):1611-9. PubMed ID: 21823211
[TBL] [Abstract][Full Text] [Related]
20. Role of Cripto-1 during epithelial-to-mesenchymal transition in development and cancer.
Rangel MC; Karasawa H; Castro NP; Nagaoka T; Salomon DS; Bianco C
Am J Pathol; 2012 Jun; 180(6):2188-200. PubMed ID: 22542493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
